Clinical trial
Smith-Lemli-Opitz Syndrome: A Pilot Study of Cholic Acid Supplementation
NCT03720990 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Smith-Lemli-Opitz Syndrome: A Pilot Study of Cholic Acid Supplementation
- Lead sponsor
- University of Nebraska
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 27, 2021
- Completion date
- September 30, 2023
- Enrollment
- 12 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.